The store will not work correctly when cookies are disabled.
1-Cyclopentyl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide
ID: ALA1090420
PubChem CID: 45378362
Max Phase: Preclinical
Molecular Formula: C16H24N2O4S
Molecular Weight: 340.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc2c(cc1OC)C(C1CCCC1)N(S(N)(=O)=O)CC2
Standard InChI: InChI=1S/C16H24N2O4S/c1-21-14-9-12-7-8-18(23(17,19)20)16(11-5-3-4-6-11)13(12)10-15(14)22-2/h9-11,16H,3-8H2,1-2H3,(H2,17,19,20)
Standard InChI Key: USTNFAJVFHIJIS-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
14.0041 -5.1615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0029 -5.9886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7177 -6.4014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7159 -4.7488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4311 -5.1578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4346 -5.9907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1535 -6.4019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8738 -5.9848 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8704 -5.1519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1467 -4.7361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5892 -6.3953 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.3025 -5.9809 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1716 -7.1069 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.9965 -7.1069 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.2883 -6.4005 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.5743 -5.9875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2897 -4.7492 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.5755 -5.1618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1558 -7.2268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4926 -7.7158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7495 -8.4995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5744 -8.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8271 -7.7122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8 11 1 0
11 12 1 0
2 3 1 0
11 13 2 0
3 6 2 0
11 14 2 0
1 2 2 0
2 15 1 0
5 4 2 0
15 16 1 0
4 1 1 0
1 17 1 0
5 10 1 0
17 18 1 0
6 7 1 0
7 19 1 0
19 20 1 0
7 8 1 0
8 9 1 0
9 10 1 0
5 6 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 340.45 | Molecular Weight (Monoisotopic): 340.1457 | AlogP: 2.00 | #Rotatable Bonds: 4 |
Polar Surface Area: 81.86 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.70 | CX Basic pKa: ┄ | CX LogP: 1.63 | CX LogD: 1.63 |
Aromatic Rings: 1 | Heavy Atoms: 23 | QED Weighted: 0.91 | Np Likeness Score: -0.06 |
References
1. Gitto R, Agnello S, Ferro S, De Luca L, Vullo D, Brynda J, Mader P, Supuran CT, Chimirri A.. (2010) Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies., 53 (6): [PMID:20170095] [10.1021/jm9014026] |